🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Harry D. Bear

Virginia Commonwealth University

ORCID: 0000-0002-7632-9019
Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “T-cell immune checkpoint inhibition plus hypomethylation for locally advanced HER2-negative breast cancer: a phase 2 neoadjuvant window trial of decitabine and pembrolizumab followed by standard neoadjuvant chemotherapy”.

T-cell immune checkpoint inhibition plus hypomethylation for locally advanced HER2-negative breast cancer: a phase 2 neoadjuvant window trial of decitabine and pembrolizumab followed by standard neoadjuvant chemotherapy

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-010294
N/A
0.510DataRank · unranked
16 citations

Xiaoyan Deng, Dipankar Bandyopadhyay, Michael O. Idowu, Taylor M. Jenkins, Maciej Kmieciak +16 more

Local and distant tumor dormancy during early stage breast cancer are associated with the predominance of infiltrating T effector subsets

Breast Cancer Research(2020)10.1186/s13058-020-01357-9
N/A
0DataRank · unranked
19 citations

Cara Coleman, Melika Zarei, Saeed H. Manjili, Laura Graham, Jennifer E. Koblinski +9 more

The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer

BMC Immunology(2020)10.1186/s12865-020-0337-5
N/A
0DataRank · unranked
41 citations

Laura Graham, Timothy M. Smith, C. Camarena, Matt P. Zellner, Jamie-Jean S. Gilmer +5 more

The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer

Research Square(2020)10.21203/rs.2.15818/v2
N/A
0DataRank · unranked
1 citations

Laura Graham, Timothy Smith, Carmen Camarena, Matthew Zellner, Jamie-Jean S Gilmer +5 more

Immunologically programming the tumor microenvironment induces the pattern recognition receptor NLRC4-dependent antitumor immunity

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-001595
N/A
0DataRank · unranked
19 citations

Wenjie Liu, Shixian Chen, Xueqian Cheng, Patrick A Paez, Tuanwei Sun +10 more

Neighborhood disadvantage and biological aging biomarkers among breast cancer patients

Scientific Reports(2022)10.1038/s41598-022-15260-0
N/A
0DataRank · unranked
56 citations

Bernard F. Fuemmeler, Vanessa B. Sheppard, Harry D. Bear, Renduo Song, Wong‐Ho Chow +2 more

Persistent EGFR/K-RAS/SIAH pathway activation drives chemo-resistance and early tumor relapse in triple-negative breast cancer

Cancer Drug Resistance(2022)10.20517/cdr.2022.31
N/A
0DataRank · unranked
16 citations

Richard Hoefer, Mary L. Guye, Harry D. Bear, Amy Tang

Neighborhood disadvantage and biological aging biomarkers among breast cancer patients

Research Square(2022)10.21203/rs.3.rs-1366192/v1
N/A
0DataRank · unranked
3 citations

Bernard F. Fuemmeler, Vanessa B. Sheppard, Harry D. Bear, Renduo Song, Wong‐Ho Chow +2 more

Adoptive immunotherapy with cells from tumor-draining lymph nodes activated and expanded in vitro

Methods in cell biology(2023)10.1016/bs.mcb.2023.04.002
N/A
0DataRank · unranked
1 citations

Laura Graham, Harry D. Bear, Carolyn Haynes

Allostatic Load and Racial and Rural Disparities in Breast Cancer Survival

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.28019
N/A
0DataRank · unranked
5 citations

Roger T. Anderson, Supraja Gururaj, Wendy Cohn, Philip I. Chow, Bernard F. Fuemmeler +4 more

Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies

Cancers(2020)10.3390/cancers12092392
N/A
0DataRank · unranked
342 citations

Amber L. Collier, Dasom Lee, Richard Hoefer, Vasilena Zheleva, Lauren L. Siewertsz van Reesema +11 more

Targeting Bcl-xL to eliminate chemotherapy-induced tumor dormancy and prevent breast cancer metastasis

British Journal of Cancer(2025)10.1038/s41416-025-03292-y
N/A
0DataRank · unranked
2 citations

Nicholas Koelsch, Victoria Neely, Laura A. Graham, Harry D. Bear, Michael O. Idowu +3 more